Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

688 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The role of ABO blood groups in glial neoplasms.
Alkan A, Yazıcı G, Cengiz M, Karakaş Y, Çelik İ, Kars A, Zorlu F. Alkan A, et al. Among authors: celik i. Br J Neurosurg. 2019 Feb;33(1):43-46. doi: 10.1080/02688697.2018.1522415. Epub 2018 Nov 4. Br J Neurosurg. 2019. PMID: 30394124
Prognostic factors for survival in patients with mucosal and ocular melanoma treated with ipilimumab: Turkish Oncology Group study.
Arzu Yaşar H, Turna H, Esin E, Murat Sedef A, Alkan A, Oksuzoglu B, Ozdemir N, Sendur MN, Sezer A, Kılıckap S, Utkan G, Akbulut H, Celik I, Abalı H, Urun Y. Arzu Yaşar H, et al. Among authors: celik i. J Oncol Pharm Pract. 2020 Mar;26(2):267-272. doi: 10.1177/1078155219840796. Epub 2019 Mar 29. J Oncol Pharm Pract. 2020. PMID: 30924738
Long-term complications in Hodgkin's lymphoma survivors.
Kilickap S, Barista I, Ulger S, Celik I, Selek U, Güllü I, Yildiz F, Kars A, Ozisik Y, Tekuzman G. Kilickap S, et al. Among authors: celik i. Tumori. 2012 Sep-Oct;98(5):601-6. doi: 10.1177/030089161209800510. Tumori. 2012. PMID: 23235755
Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study.
Urun Y, Yasar HA, Turna H, Esin E, Sedef AM, Alkan A, Oksuzoglu B, Ozdemir N, Sendur MN, Sezer A, Kılıckap S, Utkan G, Akman T, Akbulut H, Celik I, Abalı H. Urun Y, et al. Among authors: celik i. J Oncol Pharm Pract. 2019 Oct;25(7):1658-1664. doi: 10.1177/1078155218805539. Epub 2018 Nov 6. J Oncol Pharm Pract. 2019. PMID: 30400750
Modified ESHAP as salvage chemotherapy for recurrent or refractory non-Hodgkin's lymphoma: results of a single-center study of 32 patients. Modified etoposide, methylprednisolone, cytarabine and cisplatin.
Oztürk MA, Barişta I, Altundağ MK, Türker A, Yalçin S, Celik I, Güllü I, Güler N, Ozişik Y, Kars A, Kansu E, Baltali E, Tekuzman G. Oztürk MA, et al. Among authors: celik i. Chemotherapy. 2002 Dec;48(5):252-8. doi: 10.1159/000066768. Chemotherapy. 2002. PMID: 12476042 Clinical Trial.
688 results